Holen Sie sich die Stockscreener-App
9.72
0.51%
-0.05
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$9.77
Offen:
$9.7
24-Stunden-Volumen:
109.12K
Relative Volume:
0.16
Marktkapitalisierung:
$446.00M
Einnahmen:
$524.73M
Nettoeinkommen (Verlust:
$31.70M
KGV:
14.69
EPS:
0.6617
Netto-Cashflow:
$22.47M
1W Leistung:
-4.33%
1M Leistung:
-20.72%
6M Leistung:
-40.95%
1J Leistung:
-18.04%
1-Tages-Spanne:
$9.475
$9.7389
1-Wochen-Bereich:
$9.725
$10.28
52-Wochen-Spanne:
$9.475
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Compare CLB vs SLB, BKR, TS, HAL, FTI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
9.72 | 446.00M | 524.73M | 31.70M | 22.47M | 0.6617 |
SLB
Slb Ltd
|
47.86 | 71.02B | 35.91B | 3.38B | 4.41B | 2.2806 |
BKR
Baker Hughes Co
|
53.85 | 53.46B | 27.89B | 3.15B | 2.29B | 3.1363 |
TS
Tenaris Sa Adr
|
57.46 | 29.01B | 12.19B | 2.03B | 1.87B | 3.8072 |
HAL
Halliburton Co
|
32.55 | 27.11B | 22.37B | 1.61B | 1.73B | 1.9091 |
FTI
Technipfmc Plc
|
68.09 | 26.70B | 10.17B | 1.08B | 1.34B | 2.6138 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-08-13 | Hochstufung | Johnson Rice | Hold → Buy |
| 2025-03-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Bestätigt | Cowen | Market Perform |
| 2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
| 2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Bestätigt | Cowen | Market Perform |
| 2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2019-12-31 | Bestätigt | Cowen | Market Perform |
| 2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
| 2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
Form 4 Core Laboratories NV For: 5 October - Investing.com India
Form 4 Core Laboratories NV For: 5 October By Investing.com - Investing.com Australia
Form 4 Core Laboratories NV For: 5 October By Investing.com - Investing.com Canada
Core Laboratories Inc. (CLB) Stock Forecasts - Yahoo Finance
Core Laboratories Inc. (CLB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Core Laboratories sets Oct 29 call for Q3FY26 results - scanx.trade
After the Oct. 28 close, Core Laboratories will release its results; a webcast follows next morning. - Stock Titan
CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL - TradingView
CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL - Moomoo
CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL - Yahoo Finance
CLB Declines 35% in the Past Six Months: How to Play the Stock? - tradingview.com
CLB Declines 35% in the Past Six Months: How to Play the Stock? - TradingView
CLB Declines 35% in the Past Six Months: How to Play the Stock? - Yahoo Finance
Top Core Laboratories (CLB) Competitors 2026 - MarketBeat
Zacks Research Cuts Earnings Estimates for Core Laboratories - MarketBeat
Zacks Research Expects Weaker Earnings for Core Laboratories - MarketBeat
Global Perforating Gun Market Entering High-Growth Phase - openPR.com
Legal & General Group Plc Buys Shares of 122,575 Core Laboratories Inc. $CLB - MarketBeat
Bank of New York Mellon Corp Makes New Investment in Core Laboratories Inc. $CLB - MarketBeat
Zacks Industry Outlook Highlights TechnipFMC, Oceaneering International, Inc. and Core Laboratories - finance.yahoo.com
Zacks Industry Outlook Highlights TechnipFMC, Oceaneering International, Inc. and Core Laboratories - Eastern Progress
Core Porosity Analyzers Market - Future Market Insights
3 Oilfield Services Stocks Poised to Gain Despite Industry Challenges - TradingView
BlackRock Inc. Makes New Investment in Core Laboratories Inc. $CLB - MarketBeat
Bank of America Corp DE Has $3.77 Million Position in Core Laboratories Inc. $CLB - MarketBeat
Core Laboratories NV (CLB) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue? - finance.yahoo.com
Core Laboratories NV (CLB) Key Financial Ratios – Valuation, Profitability & More - Value Research
Kwaku Temeng to Resign from Core Laboratories Board, Effective Oct 1, 2026 - TradingView
Core Laboratories (NYSE: CLB) director resigns over strategy dispute - Stock Titan
Core (CLB) Quarter in Focus: Profit Per Share Clears Its Benchmark in the Latest Session - vinanet.vn
Gulfport Energy and Mobility Global Set to Join S&P SmallCap 600 - easternprogress.com
Core Laboratories Inc. CLB Stock Forecast & Price Target - Yahoo Finance
Q4 EPS Forecast for Core Laboratories Lifted by Analyst - MarketBeat
John Rogers Buys Core Laboratories Inc (CLB) -- Shares Look 28% Undervalued on GF Value - GuruFocus
Canuc Announces New Board Member - TMX Newsfile
What is Zacks Research's Forecast for CLB FY2026 Earnings? - MarketBeat
101,648 Shares in Core Laboratories Inc. $CLB Purchased by Rice Hall James & Associates LLC - MarketBeat
3 Reasons CLB is Risky and 1 Stock to Buy Instead - Yahoo Finance
CLB Q2 2026 Earnings: EPS Beats by 25.1% as Operational Execution Drives ResultsFinancial Summary - vinanet.vn
Renaissance Technologies LLC Sells 132,797 Shares of Core Laboratories Inc. $CLB - MarketBeat
Core Laboratories (CLB) Holds Above $12.40 as Oilfield Services Sector StabilizesTriple Top - vinanet.vn
Disciplined Growth Investors (CLB) reports 6.6% Core Laboratories stake on Schedule 13G/A - Stock Titan
Ariel Investments (CLB) discloses 30.5% Core Laboratories stake in Schedule 13G/A - Stock Titan
Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Johnson Rice - MarketBeat
Core Laboratories Inc. (CLB) stock price, news, quote and history - Yahoo Finance Australia
Core Laboratories Inc. (HJ1.F) stock price, news, quote and history - Yahoo Finance UK
Reservoir Analysis Market Research Explores Growth Within A $14.7 Billion Opportunity - openPR.com
CLB Q2 2026 Earnings: EPS Beats Estimates by 25.14%, Delivering a Notable Upside SurpriseEarnings Whisper Number - vinanet.vn
Core Laboratories N.V. (CLB) stock price, news, quote and history - Yahoo Finance UK
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Core Laboratories Inc-Aktie (CLB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Teo Sow Hang | CAO & Treasurer |
Oct 01 '26 |
Option Exercise |
0.00 |
250 |
0 |
8,917 |
| Teo Sow Hang | CAO & Treasurer |
Aug 01 '26 |
Option Exercise |
0.00 |
440 |
0 |
8,775 |
| Tattoli Mark Damian | SVP, Gen Counsel & Secretary |
Aug 01 '26 |
Option Exercise |
0.00 |
250 |
0 |
27,764 |
| Bruno Lawrence | Chairman and CEO |
Jul 31 '26 |
Buy |
10.78 |
5,000 |
53,900 |
262,438 |
| Tattoli Mark Damian | SVP, Gen Counsel & Secretary |
May 01 '26 |
Option Exercise |
0.00 |
250 |
0 |
27,611 |
| Carnes Martha Z. | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
54,397 |
| MARTINOVICH ROBERT F | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
8,069 |
| Murray Katherine | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
29,290 |
| ANASTASIO CURT | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
23,805 |
| Klingensmith Harvey Robert | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
8,069 |
0 |
50,031 |
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):